Particle.news

Anahí de Cárdenas Resumes Preventive Triptorelin Therapy After Pregnancy Pause

She reports no active disease, with genetic test results pending to guide any further preventive steps.

Overview

  • The actress confirmed she has restarted triptorelin injections that suppress ovarian function as part of her long‑term breast‑cancer prevention plan.
  • She said the medication brings difficult emotional side effects and has left her feeling low at times.
  • Before pausing to become pregnant, she completed four years on the regimen and now plans roughly one more year per medical advice.
  • She recently underwent a genetic test to assess inherited risk, and she is waiting for the results to inform future decisions.
  • She indicated she hopes to have another child within the next year, a plan that could shape the timing of further treatment.